Shanghai Fosun Pharmaceutical 'H'

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Shanghai Fosun Pharmaceutical 'H' has already paid €0.0496 in dividends. The last payout was in August.

Financials

In the last quarter, Shanghai Fosun Pharmaceutical 'H' had revenue of €2.59B and net profit of €218.95M

(EUR)	June 2026	YoY
Revenue	2.59B	116.80%
Gross profit	1.28B	121.53%
Net profit	218.95M	97.27%
EBITDA	397.05M	0.47%

Fundamentals

Metric	Value
Market capitalization	€7.05B
Number of shares	3.75B
52-week high/low	€2.79 - €1.70
Dividend yield	2.65%
Dividends TTM	€0.0496
Beta	0.44
P/E ratio	18.11
PEG ratio	4.45
P/B ratio	1.26
P/S ratio	1.45

Company profile

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Name	Shanghai Fosun Pharmaceutical 'H'
CEO	Yi Liu
Headquarters	Shanghai, sh USA
Website	fosunpharma.com
Sector	Communication Services
IPO	07/13/2023
Employees	40,603